{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:53:06Z","timestamp":1789084386337,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Bureau Foundation of Zhejiang Province","award":["2023KY479"],"award-info":[{"award-number":["2023KY479"]}]},{"name":"Basic Scientific Research Funds of Department of Education of Zhejiang Province","award":["KYQN202110"],"award-info":[{"award-number":["KYQN202110"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY24H080004"],"award-info":[{"award-number":["LY24H080004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Traditional Medicine Administration Bureau Foundation of Zhejiang Province","award":["2022ZQ012"],"award-info":[{"award-number":["2022ZQ012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03156-0","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:44:28Z","timestamp":1754750668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A differential diagnostic model based on immunological evaluation and routine laboratory tests: distinguishing multiple myeloma from other disorders with aberrant immunoglobulin elevation"],"prefix":"10.1007","volume":"16","author":[{"given":"Manning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"3156_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111:2962\u201372.","journal-title":"Blood"},{"key":"3156_CR2","doi-asserted-by":"publisher","first-page":"13366","DOI":"10.18632\/oncotarget.24351","volume":"9","author":"L Rao","year":"2018","unstructured":"Rao L, De Veirman K, Giannico D, Saltarella I, Desantis V, Frassanito MA, et al. Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin(\u00ae) protein MP0250: a preclinical study. Oncotarget. 2018;9:13366\u201381.","journal-title":"Oncotarget"},{"key":"3156_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood.2020009752","volume":"137","author":"AM Goodman","year":"2021","unstructured":"Goodman AM, Kim MS, Prasad V. Persistent challenges with treating multiple myeloma early. Blood. 2021;137:456\u20138.","journal-title":"Blood"},{"key":"3156_CR4","doi-asserted-by":"publisher","first-page":"e0194788","DOI":"10.1371\/journal.pone.0194788","volume":"13","author":"DA Howell","year":"2018","unstructured":"Howell DA, Hart RI, Smith AG, Macleod U, Patmore R, Cook G, et al. Myeloma: patient accounts of their pathways to diagnosis. PLoS ONE. 2018;13:e0194788.","journal-title":"PLoS ONE"},{"key":"3156_CR5","first-page":"497","volume":"327","author":"J Silberstein","year":"2022","unstructured":"Silberstein J, Tuchman S, Grant SJ. What Is Multiple Myeloma? Jama. 2022;327:497.","journal-title":"What Is Multiple Myeloma? Jama"},{"key":"3156_CR6","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3324\/haematol.2018.189159","volume":"103","author":"J Caers","year":"2018","unstructured":"Caers J, Garderet L, Kort\u00fcm KM, O\u2019Dwyer ME, van de Donk N, Binder M, et al. European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica. 2018;103:1772\u201384.","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"3156_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","volume":"37","author":"SV Rajkumar","year":"2019","unstructured":"Rajkumar SV. Multiple myeloma: every year a new standard? Hematol Oncol. 2019;37(Suppl 1):62\u20135.","journal-title":"Hematol Oncol"},{"key":"3156_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: A review. JAMA. 2022;327:464\u201377.","journal-title":"JAMA"},{"key":"3156_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imm.13176","volume":"160","author":"X Chi","year":"2020","unstructured":"Chi X, Li Y, Qiu X. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation. Immunology. 2020;160:233\u201347.","journal-title":"Immunology"},{"key":"3156_CR10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00277-017-3084-9","volume":"96","author":"A Jurczyszyn","year":"2017","unstructured":"Jurczyszyn A, Gozzetti A, Gdula-Argasi\u0144ska J, Czepiel J, Vij R, Fiala M, et al. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study. Ann Hematol. 2017;96:1693\u20138.","journal-title":"Ann Hematol"},{"key":"3156_CR11","first-page":"264","volume":"70","author":"SP Sheikh","year":"2020","unstructured":"Sheikh SP, Irfan SM, Sheikh SS. Types of paraproteinemia in patients with multiple myeloma: A cross-sectional study. JPMA J Pakistan Med Association. 2020;70:264\u20137.","journal-title":"JPMA J Pakistan Med Association"},{"key":"3156_CR12","doi-asserted-by":"crossref","unstructured":"Zhang L, Qi JY, Qi PJ, Wang YF, Zou DH, Yao HJ et al. Comparison among immunologically different subtypes of 595 untreated multiple myeloma patients in northern China. Clinical lymphoma, myeloma & leukemia. 2010; 10: 197\u2013204.","DOI":"10.3816\/CLML.2010.n.031"},{"key":"3156_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/bjh.14026","volume":"174","author":"NM Harutyunyan","year":"2016","unstructured":"Harutyunyan NM, Vardanyan S, Ghermezi M, Gottlieb J, Berenson A, Andreu-Vieyra C, et al. Levels of uninvolved Immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients. Br J Haematol. 2016;174:81\u20137.","journal-title":"Br J Haematol"},{"key":"3156_CR14","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1038\/s41375-020-01051-x","volume":"34","author":"M Ho","year":"2020","unstructured":"Ho M, Patel A, Goh CY, Moscvin M, Zhang L, Bianchi G. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Leukemia. 2020;34:3111\u201325.","journal-title":"Leukemia"},{"key":"3156_CR15","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1096\/fj.07-8073com","volume":"21","author":"Z Chen","year":"2007","unstructured":"Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2007;21:2931\u20138.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"3156_CR16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/00007611-200295100-00010","volume":"95","author":"B Yildirim","year":"2002","unstructured":"Yildirim B, Sezgin N, Sari R, Sevinc A, Hilmioglu F. Complement and Immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis. South Med J. 2002;95:1158\u201362.","journal-title":"South Med J"},{"key":"3156_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.6004\/jnccn.2022.0002","volume":"20","author":"NS Callander","year":"2022","unstructured":"Callander NS, Baljevic M, Adekola K, Anderson LD, Campagnaro E, Castillo JJ, et al. NCCN Guidelines\u00ae insights: multiple myeloma, version 3.2022. J Natl Compr Cancer Network: JNCCN. 2022;20:8\u201319.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"key":"3156_CR18","doi-asserted-by":"publisher","first-page":"102284","DOI":"10.1016\/j.ctrv.2021.102284","volume":"100","author":"P Rodriguez-Otero","year":"2021","unstructured":"Rodriguez-Otero P, Paiva B, San-Miguel JF. Roadmap to cure multiple myeloma. Cancer Treat Rev. 2021;100:102284.","journal-title":"Cancer Treat Rev"},{"key":"3156_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00277-023-05115-7","volume":"102","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Pan J, Kang H, Peng S, Tung TH, Shen B. Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments. Ann Hematol. 2023;102:801\u20139.","journal-title":"Ann Hematol"},{"key":"3156_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016;43:676\u201381.","journal-title":"Semin Oncol"},{"key":"3156_CR21","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348.","journal-title":"Lancet Oncol"},{"key":"3156_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1745-7599.2006.00122.x","volume":"18","author":"C Dvorak","year":"2006","unstructured":"Dvorak C. Common complaints, difficult diagnosis: multiple myeloma. J Am Acad Nurse Pract. 2006;18:190\u20134.","journal-title":"J Am Acad Nurse Pract"},{"key":"3156_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3122\/jabfm.2016.06.150393","volume":"29","author":"N Goldschmidt","year":"2016","unstructured":"Goldschmidt N, Zamir L, Poperno A, Kahan NR, Paltiel O. Presenting signs of multiple myeloma and the effect of diagnostic delay on the prognosis. J Am Board Family Medicine: JABFM. 2016;29:702\u20139.","journal-title":"J Am Board Family Medicine: JABFM"},{"key":"3156_CR24","doi-asserted-by":"crossref","unstructured":"Cui R, Zhang S, Wang M, Jia T, Zhai Y, Yue Y et al. Establishment of multiple myeloma diagnostic model based on logistic regression in clinical laboratory. Clin Lab. 2020; 66.","DOI":"10.7754\/Clin.Lab.2019.190832"},{"key":"3156_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/intimm\/dxx025","volume":"29","author":"S Bournazos","year":"2017","unstructured":"Bournazos S, Ravetch JV. Diversification of IgG effector functions. Int Immunol. 2017;29:303\u201310.","journal-title":"Int Immunol"},{"key":"3156_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.clinbiochem.2019.09.004","volume":"74","author":"O Evliyaoglu","year":"2019","unstructured":"Evliyaoglu O, van Helden J, Jaruschewski S, Im\u00f6hl M, Weiskirchen R. Reference change values of M-protein, free light chain and Immunoglobulins in monoclonal gammopathy. Clin Biochem. 2019;74:42\u20136.","journal-title":"Clin Biochem"},{"key":"3156_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2018.01.010","volume":"479","author":"H Chae","year":"2018","unstructured":"Chae H, Han E, Yoo J, Lee J, Lee JJ, Cha K, et al. Heavy\/light chain assay as a biomarker for diagnosis and follow-up of multiple myeloma. Clin Chim Acta. 2018;479:7\u201313.","journal-title":"Clin Chim Acta"},{"key":"3156_CR28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121\u20137.","journal-title":"Leukemia"},{"key":"3156_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/ejh.13466","volume":"105","author":"L Wu","year":"2020","unstructured":"Wu L, Xia M, Sun X, Han X, Zu Y, Jabbour EJ, et al. High levels of Immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia. Eur J Haematol. 2020;105:449\u201359.","journal-title":"Eur J Haematol"},{"key":"3156_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41420-021-00550-9","volume":"7","author":"J Zhao","year":"2021","unstructured":"Zhao J, Peng H, Gao J, Nong A, Hua H, Yang S, et al. Current insights into the expression and functions of tumor-derived Immunoglobulins. Cell Death Discovery. 2021;7:148.","journal-title":"Cell Death Discovery"},{"key":"3156_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02208084","volume":"14","author":"A Haraldsson","year":"1995","unstructured":"Haraldsson A, Tiddens HA, Fiselier T, Bakkeren JA, Weemaes CM. Altered Immunoglobulin concentrations and light chain ratios in juvenile onset mixed connective tissue disease. Clin Rheumatol. 1995;14:51\u20134.","journal-title":"Clin Rheumatol"},{"key":"3156_CR32","unstructured":"Yu Y, Teng XJ, Luo GL, Wu LX, Guo BQ. [Value of serum light chain in diagnosis and evaluation of efficacy for multiple myeloma]. Zhongguo Shi Yan Xue ye Xue Za Zhi. 2020; 28: 886\u201393."},{"key":"3156_CR33","first-page":"2255800","volume":"28","author":"A Lei","year":"2023","unstructured":"Lei A, Liao X, Zhu P, Xiong M. The significance of autologous hematopoietic stem cell transplantation on Immunoglobulin reconstitution and prognosis in elderly patients with multiple myeloma. Hematol (Amsterdam Netherlands). 2023;28:2255800.","journal-title":"Hematol (Amsterdam Netherlands)"},{"key":"3156_CR34","doi-asserted-by":"crossref","unstructured":"Liu X, Zhou Z, Sun D. Values of Immunoglobulin and complements for evaluating treatment outcomes of patients with multiple myeloma. Clin Lab. 2023; 69.","DOI":"10.7754\/Clin.Lab.2023.230210"},{"key":"3156_CR35","first-page":"7271","volume":"30","author":"PNC Travassos","year":"2022","unstructured":"Travassos PNC, de Barros Silva PG, Freitas MO, Braga MDM, Duarte FB, de Oliveira Maia JK, et al. Risk factors for renal impairment in patients with hematological cancer receiving antineoplastic treatment. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2022;30:7271\u201380.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"key":"3156_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajh.23731","volume":"89","author":"K Kim","year":"2014","unstructured":"Kim K, Lee JH, Kim JS, Min CK, Yoon SS, Shimizu K, et al. Clinical profiles of multiple myeloma in Asia-An Asian myeloma network study. Am J Hematol. 2014;89:751\u20136.","journal-title":"Am J Hematol"},{"key":"3156_CR37","first-page":"235","volume":"1","author":"H Shi","year":"2016","unstructured":"Shi H, Chen Z, Xie J, Chen N. The prevalence and management of multiple Myeloma-Induced kidney disease in China. Kidney Dis (Basel Switzerland). 2016;1:235\u201340.","journal-title":"Kidney Dis (Basel Switzerland)"},{"key":"3156_CR38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/leu.2015.15","volume":"29","author":"R Khan","year":"2015","unstructured":"Khan R, Apewokin S, Grazziutti M, Yaccoby S, Epstein J, van Rhee F, et al. Renal insufficiency retains adverse prognostic implications despite renal function improvement following total therapy for newly diagnosed multiple myeloma. Leukemia. 2015;29:1195\u2013201.","journal-title":"Leukemia"},{"key":"3156_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ajh.24756","volume":"92","author":"M Mohan","year":"2017","unstructured":"Mohan M, Buros A, Mathur P, Gokden N, Singh M, Susanibar S, et al. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease. Am J Hematol. 2017;92:739\u201345.","journal-title":"Am J Hematol"},{"key":"3156_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","volume":"41","author":"A Negre-Salvayre","year":"2006","unstructured":"Negre-Salvayre A, Dousset N, Ferretti G, Bacchetti T, Curatola G, Salvayre R. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med. 2006;41:1031\u201340.","journal-title":"Free Radic Biol Med"},{"key":"3156_CR41","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/s41375-020-01081-5","volume":"35","author":"SM Jeong","year":"2021","unstructured":"Jeong SM, Choi T, Kim D, Han K, Kim SJ, Rhee SY, et al. Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy. Leukemia. 2021;35:1356\u201364.","journal-title":"Leukemia"},{"key":"3156_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-020-00963-6","volume":"13","author":"KM Pedersen","year":"2020","unstructured":"Pedersen KM, \u00c7olak Y, Bojesen SE, Nordestgaard BG. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals. J Hematol Oncol. 2020;13:129.","journal-title":"J Hematol Oncol"},{"key":"3156_CR43","doi-asserted-by":"publisher","first-page":"20964","DOI":"10.1002\/cam4.6649","volume":"12","author":"L Li","year":"2023","unstructured":"Li L, Yu Z, Ren J, Niu T. Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study. Cancer Med. 2023;12:20964\u201375.","journal-title":"Cancer Med"},{"key":"3156_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jacl.2020.04.001","volume":"14","author":"H Tavori","year":"2020","unstructured":"Tavori H, Ormseth MJ, Lilley JS, Papen CR, May-Zhang LS, Davies SS, et al. Progressively decreasing plasma high-density lipoprotein cholesterol levels preceding diagnosis of smoldering myeloma. J Clin Lipidol. 2020;14:293\u20136.","journal-title":"J Clin Lipidol"},{"key":"3156_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.athplu.2023.09.003","volume":"54","author":"A Makris","year":"2023","unstructured":"Makris A, Pagkali A, Nikolousis E, Filippatos TD, Agouridis AP. High-density lipoprotein cholesterol and multiple myeloma: A systematic review and meta-analysis. Atherosclerosis Plus. 2023;54:7\u201313.","journal-title":"Atherosclerosis Plus"},{"key":"3156_CR46","doi-asserted-by":"crossref","unstructured":"Erdo\u011fan \u00d6z\u00fcnal I, K\u0131l\u0131\u00e7aslan E, Elibol T, \u00d6zt\u00fcrk E. High-density lipoprotein (HDL) has an impact on myeloma outcome: Lower HDL associates with worse progression-free survival. Wiener klinische Wochenschrift. 2024; 136: 398-404.","DOI":"10.1007\/s00508-023-02239-8"},{"key":"3156_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/10408363.2014.992064","volume":"52","author":"GL Salvagno","year":"2015","unstructured":"Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52:86\u2013105.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3156_CR48","doi-asserted-by":"crossref","unstructured":"Lee H, Kong SY, Sohn JY, Shim H, Youn HS, Lee S et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. BioMed research international. 2014; 2014: 145619.","DOI":"10.1155\/2014\/145619"},{"key":"3156_CR49","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s12885-022-09902-9","volume":"22","author":"X Chen","year":"2022","unstructured":"Chen X, Liu J, Duan J, Xiong H, Liu Y, Zhang X, et al. Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis. BMC Cancer. 2022;22:796.","journal-title":"BMC Cancer"},{"key":"3156_CR50","first-page":"282","volume":"47","author":"S Meng","year":"2017","unstructured":"Meng S, Ma Z, Lu C, Liu H, Tu H, Zhang W, et al. Prognostic value of elevated red blood cell distribution width in Chinese patients with multiple myeloma. Ann Clin Lab Sci. 2017;47:282\u201390.","journal-title":"Ann Clin Lab Sci"},{"key":"3156_CR51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/CBM-170032","volume":"20","author":"J Wang","year":"2017","unstructured":"Wang J, Xie X, Cheng F, Zhou X, Xia J, Qian X, et al. Evaluation of pretreatment red cell distribution width in patients with multiple myeloma. Cancer Biomark A. 2017;20:267\u201372.","journal-title":"Cancer Biomark A"},{"key":"3156_CR52","first-page":"127","volume":"19","author":"A Gogia","year":"2018","unstructured":"Gogia A, Sikka M, Sharma S, Rusia U. Hemostatic abnormalities in multiple myeloma patients. Asian Pac J cancer Prevention: APJCP. 2018;19:127\u201330.","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"key":"3156_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/MBC.0000000000000296","volume":"26","author":"H Huang","year":"2015","unstructured":"Huang H, Li H, Li D. Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma. Blood Coagulation Fibrinolysis: Int J Haemostasis Thromb. 2015;26:555\u20139.","journal-title":"Blood Coagulation Fibrinolysis: Int J Haemostasis Thromb"},{"key":"3156_CR54","doi-asserted-by":"crossref","unstructured":"Geng C, Yang G, Wang H, Zhang Z, Zhou H, Chen W. The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma. BioMed research international. 2021; 2021: 6689457.","DOI":"10.1155\/2021\/6689457"},{"key":"3156_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ejh.13331","volume":"104","author":"C Hinterleitner","year":"2020","unstructured":"Hinterleitner C, Pecher AC, Krei\u00dfelmeier KP, Budde U, Kanz L, Kopp HG, et al. Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma. Eur J Haematol. 2020;104:26\u201335.","journal-title":"Eur J Haematol"},{"key":"3156_CR56","doi-asserted-by":"publisher","first-page":"608191","DOI":"10.3389\/fonc.2021.608191","volume":"11","author":"W Yan","year":"2021","unstructured":"Yan W, Shi H, He T, Chen J, Wang C, Liao A, et al. Employment of artificial intelligence based on routine laboratory results for the early diagnosis of multiple myeloma. Front Oncol. 2021;11:608191.","journal-title":"Front Oncol"},{"key":"3156_CR57","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s40620-020-00926-7","volume":"34","author":"ZS Lin","year":"2021","unstructured":"Lin ZS, Qin AB, Wang SX, Yu XJ, Dong B, Xiong ZY, et al. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study. J Nephrol. 2021;34:1169\u201377.","journal-title":"J Nephrol"},{"key":"3156_CR58","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/CLEP.S416028","volume":"15","author":"P Phinyo","year":"2023","unstructured":"Phinyo P, Jarupanich N, Lumkul L, Phanphaisarn A, Poosiripinyo T, Sukpanichyingyong S, et al. Validation of a diagnostic model to differentiate multiple myeloma from bone metastasis. Clin Epidemiol. 2023;15:881\u201390.","journal-title":"Clin Epidemiol"},{"key":"3156_CR59","first-page":"217","volume":"37","author":"P Mannam","year":"2022","unstructured":"Mannam P, Murali A, Gokulakrishnan P, Venkatachalapathy E, Venkata Sai PM. Radiomic analysis of Positron-Emission tomography and computed tomography images to differentiate between multiple myeloma and skeletal metastases. Indian J Nuclear Medicine: IJNM: Official J Soc Nuclear Med India. 2022;37:217\u201326.","journal-title":"Indian J Nuclear Medicine: IJNM: Official J Soc Nuclear Med India"},{"key":"3156_CR60","doi-asserted-by":"publisher","first-page":"973836","DOI":"10.3389\/fonc.2022.973836","volume":"12","author":"AG Solimando","year":"2022","unstructured":"Solimando AG, Malerba E, Leone P, Prete M, Terragna C, Cavo M, et al. Drug resistance in multiple myeloma: soldiers and weapons in the bone marrow niche. Front Oncol. 2022;12:973836.","journal-title":"Front Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03156-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:54:22Z","timestamp":1757346862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03156-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03156-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of Zhejiang Province People\u2019s Hospital, and the research was conducted in accordance with the principles outlined in the Declaration of Helsinki (Ethical approval code: QT2023128). A retrospective study was conducted on electronic medical records in this experiment, and all individuals had provided informed consent before being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1514"}}